[By order of the Board China Southern Airlines Company Limited Xie Bing Company Secretary Guangzhou, the Peoples Republic of China 15 June 2018 non-executive As at the date of this announcement, the Directors include Wang Chang Shun, Tan Wan Geng and Zhang Zi Fang as executive Directors; and Zheng F]
[Renren Announces Unaudited First Quarter 2018 Financial Results and Update on Potential Financial Impact of the Transaction Announced on April 30, 2018 BEIJING, China, June 19, 2018 — Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), which operates a social networking service (SNS) business, use]
[Renren Announces Unaudited First Quarter 2018 Financial Results and Update on Potential Financial Impact of the Transaction Announced on April 30, 2018 BEIJING, China, June 19, 2018 — Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), which operates a social networking service (SNS) business, use]
[Burford Capital Investment Management LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS AF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 7 SOLE VOTING POWER -0- 8 SHARED VOTING POWER 6,026,000 Class A Common Shares*]
[China Eastern Airlines Corporation Limited Date June 19, 2018 By Wang Jian Company Secretary 2 3]
[Burford Capital Investment Management LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ (a) ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS AF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 7 SOLE VOTING POWER -0- 8 SHARED VOTING POWER 6,026,000 Class A Common Shares*]
[China Eastern Airlines Corporation Limited Date June 19, 2018 By Wang Jian Company Secretary 2 3]
[FOR RELEASE June 19, 2018 China Biologic Announces Receipt of Non-Binding Acquisition Proposal BEIJING, China — June 19, 2018 — About China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc. (NASDAQ: CBPO) is a leading fully integrated plasma-based biopharmaceutical company in C]
[July 10, 2018 – (“China Yuchai” or the “Company”) announced today that an Interim Dividend of US$0.73 per ordinary share and a Special Dividend of US$1.48 per ordinary share for the year ended December 31, 2017 has been declared by its Board of Directors. The cash dividend will be paid on July 10, 2]
[FOR RELEASE June 19, 2018 China Biologic Announces Receipt of Non-Binding Acquisition Proposal BEIJING, China — June 19, 2018 — About China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc. (NASDAQ: CBPO) is a leading fully integrated plasma-based biopharmaceutical company in C]
